Form 10-K

$SAR reports Q4 2026 results May 5, with conference call May 6 led by CEO Oberbeck to discuss performance for quarter ended February 28.

DBV Technologies reports 296M shares outstanding and 296M voting rights as of March 31, 2026, with updates on VIASKIN® Peanut Patch clinical programs.

DBV Technologies files 2025 annual report disclosing 296M shares outstanding, 295.9M voting rights as VIASKIN Peanut development continues.

Lument Finance Trust declares $0.04 common and $0.4921875 preferred quarterly dividends; announces 2025 10-K filing March 23 and investor call March 24.

Progressive Corporation will host a capital strategy briefing on March 3, 2026, featuring CEO and CFO discussing financial positioning and investment strategy with investors.

QVC Group extended its 2025 financial results release deadline beyond February 26, 2026, citing need for additional audit and consolidation time. No accounting issues indicated.

Ambow Education submitted its 2025 Form 10-K annual report to the SEC, disclosing financial performance and business developments for the fiscal year ended December 31, 2025.